JP2022504207A5 - - Google Patents
Info
- Publication number
- JP2022504207A5 JP2022504207A5 JP2021518512A JP2021518512A JP2022504207A5 JP 2022504207 A5 JP2022504207 A5 JP 2022504207A5 JP 2021518512 A JP2021518512 A JP 2021518512A JP 2021518512 A JP2021518512 A JP 2021518512A JP 2022504207 A5 JP2022504207 A5 JP 2022504207A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- overtraining
- formula
- hydroxybutyrate
- pharmaceutically acceptable
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1816196.8A GB2577723A (en) | 2018-10-04 | 2018-10-04 | Compounds for new use |
| GB1816196.8 | 2018-10-04 | ||
| PCT/GB2019/052797 WO2020070506A1 (en) | 2018-10-04 | 2019-10-03 | Compounds for use in preventing or treating athlete overtraining |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022504207A JP2022504207A (ja) | 2022-01-13 |
| JP2022504207A5 true JP2022504207A5 (https=) | 2022-09-22 |
| JPWO2020070506A5 JPWO2020070506A5 (https=) | 2022-09-22 |
| JP7575163B2 JP7575163B2 (ja) | 2024-10-29 |
Family
ID=68242730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518512A Active JP7575163B2 (ja) | 2018-10-04 | 2019-10-03 | アスリートのオーバートレーニングの予防又は処置に用いる化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12290496B2 (https=) |
| EP (1) | EP3860584B1 (https=) |
| JP (1) | JP7575163B2 (https=) |
| KR (1) | KR102868881B1 (https=) |
| CN (1) | CN112996498B (https=) |
| AU (1) | AU2019351925B2 (https=) |
| CA (1) | CA3114889A1 (https=) |
| GB (2) | GB2577723A (https=) |
| WO (1) | WO2020070506A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202100020441A1 (it) | 2021-07-30 | 2023-01-30 | Unichem Estense S R L | Miscela di un mono-estere e un di-estere, in cui detti mono-estere e di-estere sono esteri dell’acido (R)-3-idrossibutanoico con un polialcol, processo per la preparazione della miscela e relativi usi medici |
| CN118591523A (zh) * | 2021-11-12 | 2024-09-03 | 阿萨达股份公司 | 多元醇衍生的化合物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090253781A1 (en) | 2002-05-24 | 2009-10-08 | Btg International Limited | Therapeutic compositions |
| US6323237B1 (en) | 1997-03-17 | 2001-11-27 | Btg International Limited | Therapeutic compositions |
| EP1648952B1 (en) * | 2003-06-03 | 2018-03-07 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives |
| SE0400355D0 (sv) | 2004-02-17 | 2004-02-17 | Synbiotics Ab | New synbiotec use |
| WO2006020137A2 (en) | 2004-07-16 | 2006-02-23 | Ketocytonyx Inc. | Oligomeric compounds |
| EP1778615A4 (en) | 2004-07-20 | 2010-01-06 | Btg Int Ltd | OLIGOMERE KETONE COMPOUNDS |
| CN100344280C (zh) * | 2005-08-01 | 2007-10-24 | 清华大学 | 3－羟基丁酸及其衍生物的新用途 |
| WO2008110034A1 (en) | 2007-03-14 | 2008-09-18 | Shantou University | 3-hydroxy fatty acid and its derivatives for improving of learning and/or memory of subjects |
| EP2240017B1 (en) | 2008-01-04 | 2019-03-13 | Oxford University Innovation Limited | Ketone bodies and ketone body esters as blood lipid lowering agents |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| JP5773870B2 (ja) | 2008-08-21 | 2015-09-02 | アイシス イノヴェイション リミテッド | ヒドロキシ酪酸エステル及びその医学的使用 |
| US8865641B2 (en) | 2011-06-16 | 2014-10-21 | The Feinstein Institute For Medical Research | Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways |
| GB201206192D0 (en) * | 2012-04-05 | 2012-05-23 | Tdeltas Ltd | Ketone bodies and ketone body esters and for maintaining or improving muscle power output |
| GB2515603B (en) | 2013-03-14 | 2015-10-14 | Isis Innovation | Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate |
| CA2902603C (en) | 2013-03-19 | 2021-03-02 | University Of South Florida | Compositions and methods for producing elevated and sustained ketosis |
| US11814664B2 (en) | 2013-05-24 | 2023-11-14 | Genomatica, Inc. | Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate |
| GB201314127D0 (en) * | 2013-08-07 | 2013-09-18 | Tdeltas Ltd | Ketone body and ketone body ester for reducing muscle breakdown |
| US20150283163A1 (en) * | 2014-04-04 | 2015-10-08 | Organic Medical Ventures, L.L.C. | Muscle treatment composition and method making same |
| US20180008629A1 (en) | 2015-01-29 | 2018-01-11 | Yale University | Compositions and Methods for Treating NLRP3 Inflammasome-Related Diseases and Disorders |
| EA201791982A1 (ru) | 2015-03-09 | 2020-02-17 | Интекрин Терапьютикс, Инк. | Способы лечения неалкогольной жировой болезни печени и/или липодистрофии |
| CA3021784A1 (en) | 2016-04-19 | 2017-10-26 | Keto Patent Group, Inc. | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans |
| GB201710229D0 (en) | 2017-06-27 | 2017-08-09 | Tdeltas Ltd | Compounds for new use |
-
2018
- 2018-10-04 GB GB1816196.8A patent/GB2577723A/en not_active Withdrawn
-
2019
- 2019-10-03 US US17/282,594 patent/US12290496B2/en active Active
- 2019-10-03 KR KR1020217013546A patent/KR102868881B1/ko active Active
- 2019-10-03 CN CN201980065370.4A patent/CN112996498B/zh active Active
- 2019-10-03 JP JP2021518512A patent/JP7575163B2/ja active Active
- 2019-10-03 AU AU2019351925A patent/AU2019351925B2/en active Active
- 2019-10-03 EP EP19787377.1A patent/EP3860584B1/en active Active
- 2019-10-03 GB GB2105967.0A patent/GB2592803B/en active Active
- 2019-10-03 WO PCT/GB2019/052797 patent/WO2020070506A1/en not_active Ceased
- 2019-10-03 CA CA3114889A patent/CA3114889A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020527547A5 (https=) | ||
| US8367623B2 (en) | Glycolipid and medicine for autoimmune disease containing the same as active ingredient | |
| ES3026786T3 (en) | Pemafibrate in combination with a sglt2 inhibitor for the prophylactic or therapeutic treatment of liver diseases nonalcoholic fatty liver disease | |
| JP2011502174A5 (https=) | ||
| BR112019020262A2 (pt) | composição farmacêutica para prevenir ou tratar esteato-hepatite não alcoólica (nash), composição alimentícia funcional saudável para prevenir ou tratar esteato-hepatite não alcoólica, método para prevenir ou tratar esteato-hepatite não alcoólica (nash) e uso de uma composição | |
| JP2022504207A5 (https=) | ||
| JP2021525775A5 (https=) | ||
| ES2900593T3 (es) | Composiciones que comprenden 15-HEPE y su uso para tratar o prevenir la fibrosis pulmonar idiopática | |
| US20190350890A1 (en) | Composition for preventing or treating hepatitis containing monoacetyl diacylglycerol compound | |
| US9169268B2 (en) | Use of 7-alkoxy fangchinoline compounds in preventing, alleviating and/or treating depression | |
| CN114450009A (zh) | 用于治疗肝脏疾病的尿苷磷酸化酶(upase)抑制剂 | |
| DK2310020T3 (en) | PRESENT UNKNOWN ACETATES OF 2-DEOXY MONOSACCHARIDES WITH ANTICANCER ACTIVITY | |
| RU2007107935A (ru) | Полисульфатированные гликозиды и их соли | |
| KR101558476B1 (ko) | 필버톤의 신규한 용도 | |
| US11491128B2 (en) | Reversible nitroxide derivatives of nitroalkenes that mediate nitrosating and alkylating reactions | |
| WO2020200305A1 (zh) | 一种含羟基脲的药物组合物的应用 | |
| US20210212977A1 (en) | Compounds for use in cancer cachexia | |
| GB2592803A (en) | Compounds for use in preventing or treating athlete overtraining | |
| WO1998039291A1 (fr) | Composes | |
| US20180110747A1 (en) | Use of thia oxo compounds for lowering apo c3 | |
| JPWO2020070506A5 (https=) | ||
| JPWO2019234402A5 (https=) | ||
| WO2025158806A1 (ja) | 代謝機能不全に関連した脂肪性肝疾患の予防又は改善剤 | |
| JP2018515507A5 (https=) | ||
| JP2025526296A (ja) | 代謝障害を処置するための組成物および方法 |